SBIR/STTR Research Award
STTR Phase I: An Advanced Antibiotic Screen of Marine Environmental DNA through a Metabolically Engineered E. coli Strain
Award amount
$150,000Program and phase
STTR · Phase IAward year
2007Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- EarthGenes Pharmaceuticals
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- NSF 06-598
- Topic code
- BT
Research abstract
This Small Business Technology Transfer (STTR) Phase I research project aims to develop a new method for expressing novel antimicrobials from marine microbial DNA in engineered E. coli. Availability of new antibiotics would be of great value to medicine, as more human pathogens are acquiring resistance to mainstay antibiotic therapy. Moreover, a method for expression and isolation of heterologous natural products in E. coli would also open the door to identification of products with other desired activities, such as anti-tumorigenic compounds.
Technology keywords
Not reported